You are here

  • Home
  • Archive
  • Volume 2, Issue 1
  • Efficacy of first dose of covid-19 vaccine versus no vaccination on symptoms of patients with long covid: target trial emulation based on ComPaRe e-cohort

Article info

Article menu
Research
Efficacy of first dose of covid-19 vaccine versus no vaccination on symptoms of patients with long covid: target trial emulation based on ComPaRe e-cohort

Authors

  • Viet-Thi Tran Université Paris Cité and Université Sorbonne Paris Nord, Inserm, INRAE, Center for Research in Epidemiology and StatisticS (CRESS), F-75004 Paris, FranceCentre d’Epidémiologie Clinique, AP-HP, Hôpital Hôtel Dieu, F-75004 Paris, France PubMed articlesGoogle scholar articles
  • Elodie Perrodeau Centre d’Epidémiologie Clinique, AP-HP, Hôpital Hôtel Dieu, F-75004 Paris, France PubMed articlesGoogle scholar articles
  • Julia Saldanha Université Paris Cité, Paris, France PubMed articlesGoogle scholar articles
  • Isabelle Pane Centre d’Epidémiologie Clinique, AP-HP, Hôpital Hôtel Dieu, F-75004 Paris, France PubMed articlesGoogle scholar articles
  • Philippe Ravaud Centre d’Epidémiologie Clinique, AP-HP, Hôpital Hôtel Dieu, F-75004 Paris, FranceUniversité Paris Cité, Paris, FranceDepartment of Epidemiology, Columbia University Mailman School of Public Health, New York, New York, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Viet-Thi Tran, Centre d'Epidémiologie Clinique, Hôpital Hôtel-Dieu, Assistance Publique Hôpitaux de Paris, Paris, 75004, France; thi.tran-viet{at}aphp.fr
View Full Text

Citation

Tran V, Perrodeau E, Saldanha J, et al
Efficacy of first dose of covid-19 vaccine versus no vaccination on symptoms of patients with long covid: target trial emulation based on ComPaRe e-cohort
BMJ Medicine 2023;2:e000229. doi: 10.1136/bmjmed-2022-000229

Publication history

  • Received April 15, 2022
  • Accepted November 25, 2022
  • First published February 28, 2023.
Online issue publication 
February 09, 2024
Review history

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.